BCL2 and cancer: Taken together, the complexity surrounding the regulation of apoptosis conferred either directly by BCL-2 family proteins and IAPs or indirectly by several survival pathways expands the range of therapeutics strategies available to trigger apoptosis in pediatric cancers.